Back to TD Asset Management Inc. TD Asset Management Inc.

RVMD

25 quarters

Position history for TD Asset Management Inc.TD Asset Management Inc.'s holdings in Revolution Medicines, Inc.

Yes. TD Asset Management holds 117,029 shares of RVMD (Revolution Medicines), worth $23.9M, as of its Q3 2026 13F filing. It reduced the position by 39,048 shares (-25.0%) from Q2 2026. TD Asset Management has held RVMD since Q2 2021, across 22 quarterly 13F filings.

Current Value

$23.9M

Current Shares

117,029

Total Value Change

+$23.7M

Total Shares Change

+107,659

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
117,029
-25.0%
$23.9M0.0%$205.26
0
2026-Q2
Decreased
156,077
-50.9%
$29.2M0.0%$187.28
0
2026-Q1
Decreased
317,811
-14.2%
$30.9M0.0%$97.25
0
2025-Q4
Decreased
370,520
-30.8%
$29.5M0.0%$79.65
0
2025-Q3
Increased
535,604
+5.5%
$25M0.0%$46.70
30
2025-Q2
Increased
507,600
+55.8%
$18.7M0.0%$36.79
40
2025-Q1
Increased
325,876
+15.8%
$11.5M0.0%$35.36
32
2024-Q4
Increased
281,386
+15.5%
$12.3M0.0%$43.74
32
2024-Q3
Decreased
243,534
-2.7%
$10.8M0.0%$44.17
0
2024-Q2
Decreased
250,194
-1.7%
$9.7M0.0%$38.81
0
2024-Q1
Decreased
254,594
-6.3%
$8.2M0.0%$32.23
0
2023-Q4
Decreased
271,760
-0.0%
$7.8M0.0%$28.68
0
2023-Q3
Increased
271,824
+106.2%
$7.5M0.0%$27.68
44
2023-Q2
Decreased
131,812
-2.0%
$3.5M0.0%$26.22
0
2023-Q1
Increased
134,512
+42.8%
$2.9M0.0%$21.46
35
2022-Q4
Unchanged
94,173
0.0%
$2.2M0.0%$23.82
0
2022-Q3
Increased
94,173
+17.3%
$1.8M0.0%$19.55
30
2022-Q2
Decreased
80,297
-9.2%
$1.6M0.0%$19.08
0
2022-Q1
Increased
88,400
+21.1%
$2.3M0.0%$25.59
31
2021-Q4
Unchanged
73,000
0.0%
$1.8M0.0%$25.59
0
2021-Q3
Increased
73,000
+157.0%
$2M0.0%$27.68
42
2021-Q2
New
28,400
-
$813,0000.0%$31.74
34
2020-Q3
Exited
0
-100.0%
$00.0%$33.97
0
2020-Q2
Unchanged
9,370
0.0%
$296,0000.0%$31.57
0
2020-Q1
New
9,370
-
$205,0000.0%$22.33
32

Other major holders of RVMD: FMR LLC, BlackRock, Inc., Farallon Capital Management, L.L.C., Baker Bros. Advisors LP

Optional analytics helps us improve. How it’s used